Business Description
DocMorris AG
ISIN : CH0042615283
Total Employee Number:
1,635Compare
Compare
Traded in other countries / regions
DOCM.Switzerland0RRB.UKZRE.GermanyZRSEF.USA IPO Date
2017-07-06Description
DocMorris AG operates several e-commerce pharmacies for medical and pharmaceutical products and offers professional health care services. The Company operates at the intersection of healthcare, technology, and e-commerce, with a primary focus on creating a digital health platform. Its Online pharmacy business covers the online distribution of prescription and OTC medications, health, beauty and personal care products, while Digital services cover marketplace, ecosystem, technology and telemedicine services. Customer-centric AI-powered health services provide patients with comprehensive support and care through a seamless, personalised experience. Sales are made to mail-order pharmacies and directly to private individuals. The Group's reportable segments are Germany and Europe.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.37 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.74 | |||||
Debt-to-EBITDA | -5.31 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.7 | |||||
Beneish M-Score | -2.68 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12 | |||||
3-Year EBITDA Growth Rate | 33.8 | |||||
3-Year EPS without NRI Growth Rate | 24.6 | |||||
3-Year FCF Growth Rate | 23.1 | |||||
3-Year Book Growth Rate | -17.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 50.98 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.4 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.95 | |||||
9-Day RSI | 56.96 | |||||
14-Day RSI | 55.48 | |||||
3-1 Month Momentum % | 48.82 | |||||
6-1 Month Momentum % | 94.87 | |||||
12-1 Month Momentum % | 50.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.87 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 0.72 | |||||
Days Inventory | 18.38 | |||||
Days Sales Outstanding | 19.06 | |||||
Days Payable | 25.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -27.5 | |||||
Shareholder Yield % | 6.54 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 22.1 | |||||
Operating Margin % | -7.74 | |||||
Net Margin % | -10.65 | |||||
EBITDA Margin % | -4.23 | |||||
FCF Margin % | -6.84 | |||||
OCF Margin % | -4.56 | |||||
ROE % | -30.29 | |||||
ROA % | -15.06 | |||||
ROIC % | -15.34 | |||||
3-Year ROIIC % | -22.55 | |||||
ROC (Joel Greenblatt) % | -188.89 | |||||
ROCE % | -13.41 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.42 | |||||
PB Ratio | 1.4 | |||||
EV-to-EBIT | -7.25 | |||||
EV-to-EBITDA | -13.78 | |||||
EV-to-Revenue | 0.58 | |||||
EV-to-FCF | -8.52 | |||||
Price-to-GF-Value | 1.47 | |||||
Earnings Yield (Greenblatt) % | -13.79 | |||||
FCF Yield % | -15.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DocMorris AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,275.449 | ||
| EPS (TTM) (€) | -2.801 | ||
| Beta | 0.7961 | ||
| 3-Year Sharpe Ratio | -0.29 | ||
| 3-Year Sortino Ratio | -0.35 | ||
| Volatility % | 60.01 | ||
| 14-Day RSI | 55.48 | ||
| 14-Day ATR (€) | 0.513767 | ||
| 20-Day SMA (€) | 10.525 | ||
| 12-1 Month Momentum % | 50.86 | ||
| 52-Week Range (€) | 4.3 - 12.08 | ||
| Shares Outstanding (Mil) | 50.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DocMorris AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DocMorris AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
DocMorris AG Frequently Asked Questions
What is DocMorris AG(STU:ZRE)'s stock price today?
The current price of STU:ZRE is €10.85. The 52 week high of STU:ZRE is €12.08 and 52 week low is €4.30.
When is next earnings date of DocMorris AG(STU:ZRE)?
The next earnings date of DocMorris AG(STU:ZRE) is .
Does DocMorris AG(STU:ZRE) pay dividends? If so, how much?
DocMorris AG(STU:ZRE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on DocMorris AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers